Weakness, sniffles and high temperature could be symptoms of Strangles. Often symptoms also include swollen lymph nodes in the head. If a horse has caught this condition, it can quickly infect the whole stable, as it is highly contagious. We recommend that you act responsibly and isolate your horse as soon as it is diagnosed. In this case your horse will have to undergo intensive treatment by the vet for a several weeks.
Leading scientists of the Animal Health Trust (AHT) of the Swedish University of Agricultural Sciences, the Karolinska Instititute and the Vaccine producers Intervacc AB have successfully completed their research on Strangles.
Through intensive collaboration, a vaccine was developed to fight this highly contagious and dangerous disease. This Vaccine, that will be called Strangvac® is based on protein links and uses DNA-sequences of the Strangles pathogen streptococcus equi. This is an exciting milestone in the gene based research. In the practice study the new vaccine has been successfully tested on a group of horses and has shown a success rate of 80 %.
The vaccine itself will be available on the market in about two years. In the meantime registrations and market introductions have commenced. Optimisation of the production process for sufficient amounts of vaccines is also underway. Furthermore, the contract between Intervacc and 3P Biopharmaceuticals in Pamplona/Spain is secured. This is for the production of the vaccine and to ensure the basis of the official introduction into the market. The vaccine Strangvac® should be available in 2020.
(click here to read more about “Strangvac: a recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi”)
Photo by José Alejandro Cuffia